Goldenwell Biotech, Inc. (GWLL)
PNK · Consumer Defensive · Packaged Foods
$0.52
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$51.5M
Shares Outstanding
99.0M
P/S (TTM)
826x
Exchange
PNK
Currency
USD
About Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Quarterly Financials
| Metric | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | -158.00 | 0.00 | 38K | 25K |
| Gross Profit | -85.00 | 0.00 | 38K | 25K |
| Operating Income | -19K | -32K | -3K | -6K |
| Net Income | -28K | -34K | -5K | -8K |
| Diluted EPS | $nan | $0.00 | $-0.00 | $-0.00 |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 16K | 48K | 2K | 139.00 |
| Gross Profit | 8K | 25K | 666.00 | 64.00 |
| Operating Income | -118K | -985K | -116K | -123K |
| Net Income | -117K | -985K | -117K | -131K |
| Diluted EPS | $-0.00 | $-0.01 | $0.00 | $0.00 |